Is adjuvant radiotherapy necessary for FIGO stage 1a grade 2 endometrial endometrioid adenocarcinoma?

---

Inan A. H., Ersoy G. S., Yildinm Y., Gurbuz T., KEBAPCILAR A. G., Hanhan M.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, vol.16, no.3, pp.153-157, 2015 (ESCI)

• Publication Type: Article / Article
• Volume: 16 Issue: 3
• Publication Date: 2015
• Doi Number: 10.5152/jtgga.2015.15163
• Journal Name: JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.153-157
• Open Archive Collection: AVESIS Open Access Collection
• Marmara University Affiliated: Yes

Abstract

Objective: The impact of adjuvant radiotherapy on the rates of survival and local recurrence was analyzed in patients diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage 1a grade 2 endometrial endometrioid adenocarcinoma.